Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The Montpellier-based biotech's stock fell by 2.78% to €26.62 at mid-session, in a Paris market weighed down by soaring long-term rates and a surge in…
The Montpellier-based biotech's stock fell 2.02% to €28.14 at midday in a sluggish Paris market. The SBF 120 is down 1.36% in session and the CAC 40 h…
The Montpellier-based biotech's stock picks up pace mid-session, on the eve of a highly anticipated meeting with analysts. At €26.86, the stock is up …
The biotech company from Montpellier opens the trading session on Wednesday, May 6, 2026, with a strong acceleration. The MedInCell stock climbs 4.23%…
The Montpellier-based biotech regains momentum in the mid-afternoon, following the CAC 40 which is up by 0.49% during the session. The stock is approa…
Shares of the biotech company based in Montpellier fell early in the week, in a declining Parisian market. The CAC 40 is down 0.51% during the session…
The Montpellier-based biotech stock falls 3.55% to €23.94 at mid-session, after gaining 5.51% the previous day. The movement occurs in a sluggish Pari…
The Montpellier-based biotech's stock marks one of the strongest gains in the biotech sector on Euronext Paris in mid-afternoon trading. At 24.12 euro…
On Tuesday, April 28, 2026, shares of the Montpellier-based biotech company fell by 3.61%, closing at 22.94 euros. This decline extends a challenging …
MedInCell falls by 2.48% to 23.60 euros this Friday, amidst a significant retreat in European markets. The Montpellier-based biotech stock, still show…
